Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8600 | 1169 | 57.2 | 89% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEUROPHARMACOL SECT | Address | 63 | 52% | 7% | 86 |
2 | NEUROANAT EXPT NEUROL | Address | 9 | 40% | 2% | 18 |
3 | PHARMACOL CHEM | Address | 7 | 11% | 5% | 58 |
4 | PROTHROMBIN KRINGLE 2 | Author keyword | 6 | 80% | 0% | 4 |
5 | DOPAMINERGIC NEURODEGENERATION | Author keyword | 5 | 39% | 1% | 11 |
6 | COMPREHENS INFLAMMATORY DISORDERS | Address | 4 | 26% | 1% | 14 |
7 | IDIOPATHIC PARKINSONISM | Author keyword | 4 | 44% | 1% | 7 |
8 | CELL TRANSFORMAT TORAT | Address | 4 | 38% | 1% | 8 |
9 | DOPAMINERGIC DEGENERATION | Author keyword | 3 | 43% | 1% | 6 |
10 | AGED RELATED BRAIN DIS | Address | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROTHROMBIN KRINGLE 2 | 6 | 80% | 0% | 4 | Search PROTHROMBIN+KRINGLE+2 | Search PROTHROMBIN+KRINGLE+2 |
2 | DOPAMINERGIC NEURODEGENERATION | 5 | 39% | 1% | 11 | Search DOPAMINERGIC+NEURODEGENERATION | Search DOPAMINERGIC+NEURODEGENERATION |
3 | IDIOPATHIC PARKINSONISM | 4 | 44% | 1% | 7 | Search IDIOPATHIC+PARKINSONISM | Search IDIOPATHIC+PARKINSONISM |
4 | DOPAMINERGIC DEGENERATION | 3 | 43% | 1% | 6 | Search DOPAMINERGIC+DEGENERATION | Search DOPAMINERGIC+DEGENERATION |
5 | RAT ASTROCYTOMA CELLS C6 | 3 | 100% | 0% | 3 | Search RAT+ASTROCYTOMA+CELLS+C6 | Search RAT+ASTROCYTOMA+CELLS+C6 |
6 | NEUROINFLAMMATORY | 2 | 36% | 0% | 5 | Search NEUROINFLAMMATORY | Search NEUROINFLAMMATORY |
7 | AMANTADINE TREATMENT | 2 | 67% | 0% | 2 | Search AMANTADINE+TREATMENT | Search AMANTADINE+TREATMENT |
8 | FT GEL | 2 | 67% | 0% | 2 | Search FT+GEL | Search FT+GEL |
9 | REACTIVE MICROGLIOSIS | 2 | 67% | 0% | 2 | Search REACTIVE+MICROGLIOSIS | Search REACTIVE+MICROGLIOSIS |
10 | COMPOUND 11B | 1 | 100% | 0% | 2 | Search COMPOUND+11B | Search COMPOUND+11B |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LIPOPOLYSACCHARIDE INDUCED NEUROTOXICITY | 72 | 65% | 6% | 68 |
2 | SINGLE INTRANIGRAL INJECTION | 38 | 69% | 3% | 33 |
3 | INFLAMMOGEN LIPOPOLYSACCHARIDE | 22 | 81% | 1% | 13 |
4 | INTRANIGRAL INJECTION | 20 | 49% | 2% | 29 |
5 | ROTENONE INDUCED DEGENERATION | 19 | 61% | 2% | 20 |
6 | BACTERIAL ENDOTOXIN EXPOSURE | 17 | 62% | 2% | 18 |
7 | MPTP MOUSE MODEL | 11 | 32% | 2% | 29 |
8 | REACTIVE MICROGLIA | 11 | 23% | 4% | 41 |
9 | DOPAMINERGIC NEURODEGENERATION | 10 | 27% | 3% | 32 |
10 | SYNERGISTIC DOPAMINERGIC NEUROTOXICITY | 10 | 63% | 1% | 10 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Neuroinflammation in Parkinson's disease: a target for neuroprotection? | 2009 | 448 | 159 | 55% |
Glial reactions in Parkinson's disease | 2008 | 283 | 96 | 53% |
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms | 2007 | 1192 | 221 | 23% |
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention | 2010 | 199 | 126 | 53% |
Glia: Initiators and Progressors of Pathology in Parkinson's Disease | 2011 | 89 | 130 | 36% |
Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease | 2012 | 45 | 239 | 41% |
Mechanisms Underlying Inflammation in Neurodegeneration | 2010 | 716 | 145 | 11% |
Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson's disease | 2013 | 38 | 237 | 27% |
Neuroimmunological processes in Parkinson's disease and their relation to alpha-synuclein: microglia as the referee between neuronal processes and peripheral immunity | 2013 | 19 | 246 | 47% |
Inflammation as a causative factor in the aetiology of Parkinson's disease | 2007 | 264 | 156 | 46% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEUROPHARMACOL SECT | 63 | 52% | 7.4% | 86 |
2 | NEUROANAT EXPT NEUROL | 9 | 40% | 1.5% | 18 |
3 | PHARMACOL CHEM | 7 | 11% | 5.0% | 58 |
4 | COMPREHENS INFLAMMATORY DISORDERS | 4 | 26% | 1.2% | 14 |
5 | CELL TRANSFORMAT TORAT | 4 | 38% | 0.7% | 8 |
6 | AGED RELATED BRAIN DIS | 3 | 100% | 0.3% | 3 |
7 | BURKE MED MOL NEUROBIOL | 2 | 67% | 0.2% | 2 |
8 | FRE2723 | 2 | 67% | 0.2% | 2 |
9 | TOXICOLSHINGAWA KU | 2 | 67% | 0.2% | 2 |
10 | NEURODEGENERAT CONTROL | 2 | 17% | 0.9% | 11 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000144974 | ROTENONE//3 4 DIHYDROXYPHENYLGLYCOLALDEHYDE//3 4 DIHYDROXYPHENYLACETALDEHYDE |
2 | 0.0000136468 | MICROGLIA//AMEBOID MICROGLIA//RAMIFIED MICROGLIA |
3 | 0.0000122475 | NEUROMELANIN//AMINOCHROME//5 S CYSTEINYLDOPAMINE |
4 | 0.0000114460 | TUMOR NECROSIS FACTOR CONVERTING ENZYME//KINSMEN NEUROL//FIBRILLAR PLAQUE |
5 | 0.0000111562 | MPTP//MPP//1 METHYL 4 PHENYL 1 2 3 6 TETRAHYDROPYRIDINE |
6 | 0.0000099974 | IMMUNOPATHOL INFECT DIS GROUPING IRG GRI//TLR 3//BIOMETRY MED COMP |
7 | 0.0000096340 | NEUROINFLAMMAT S//MOL NEUROSCI UNIT//BUTAPROST |
8 | 0.0000077734 | MOL CELLULAR TOXICOL HUMAN PLICAT//OULU CITY HOSP//DOOR TO DOOR SURVEYS |
9 | 0.0000074725 | ALPHA SYNUCLEIN//SYNUCLEIN//BETA SYNUCLEIN |
10 | 0.0000074220 | OXIDAT ST S ATMOSPHER POLLUT//STRUCT FUNCT NEUROSCI//NUCE |